Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Brault

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
Frontiers in Immunology|January 23, 2023
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cellsJulie Brault, Taylor Liu, Siyuan Liu, et al.
Blood|June 4, 2021
CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytesJulie Brault, Taylor Liu, Ezekiel Bello, et al.
Nature Communications|June 28, 2022
Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiencySuk See De Ravin, Siyuan Liu, Colin L Sweeney, et al.
Blood|February 24, 2021
Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cellsSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Cell Reports Methods|May 9, 2023
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cellsNaritaka Tamaoki, Stefan Siebert, Takuya Maeda, et al.
Blood Advances|December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous diseaseSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cytotherapy|October 14, 2020
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia diseaseJulie Brault, Ronald J Meis, Linhong Li, et al.
Frontiers in Immunology|January 23, 2023
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cellsJulie Brault, Taylor Liu, Siyuan Liu, et al.
Blood|June 4, 2021
CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytesJulie Brault, Taylor Liu, Ezekiel Bello, et al.
Nature Communications|June 28, 2022
Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiencySuk See De Ravin, Siyuan Liu, Colin L Sweeney, et al.
Blood|February 24, 2021
Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cellsSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Cell Reports Methods|May 9, 2023
Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cellsNaritaka Tamaoki, Stefan Siebert, Takuya Maeda, et al.
Blood Advances|December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous diseaseSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
Pageof 2